多黏菌素B血液灌流对腹膜炎所致脓毒性休克患者的升压药减量效应:倾向评分匹配分析
本研究为回顾性研究,纳入2014年7月至2021年2月首尔大学医院外科ICU收治的、因腹膜炎所致脓毒性休克行腹部大手术控制感染源的成人患者338例,其中术后接受PMX-HP者23例、未接受者315例,采用倾向评分匹配比较升压药减量效应。结果显示,无论是否应用PMX-HP,血清去甲肾上腺素浓度均随时间下降,但PMX-HP(+)组下降更快;两组人口学特征(年龄、性别、体重指数及多数基础合并症)无显著差异。PMX-HP不降低ICU死亡率。作者认为该效应可能加速休克恢复、减少升压药后遗症并最终改善出院后生活质量。
要点
- 腹膜炎所致脓毒性休克术后仍需大剂量升压药者,PMX-HP(+)组血清去甲肾上腺素浓度较PMX-HP(-)组下降更快。
- 无论是否应用PMX-HP,血清去甲肾上腺素浓度均随时间下降。
- PMX-HP不降低ICU死亡率(次要终点无显著差异)。
- 两组年龄、性别、体重指数及多数基础合并症无显著差异。
- 作者认为PMX-HP快速减少术后升压药需求可能加速休克恢复、减少升压药后遗症并改善出院后生活质量。
适用人群与场景
- 2014年7月至2021年2月首尔大学医院外科ICU收治的、因腹膜炎所致脓毒性休克行腹部大手术控制感染源的成人患者。
- 术后仍需要大剂量升压药的患者。
研究设计与关键结果
- 回顾性研究,共338例符合纳入标准,其中术后接受PMX-HP者23例、未接受者315例。
- 主要终点为升压药减量效应,次要终点为ICU死亡率。
- 采用倾向评分匹配比较升压药减量效应。
- 血清去甲肾上腺素浓度无论是否应用PMX-HP均随时间下降,但PMX-HP(+)组较PMX-HP(-)组下降更快。
- 两组年龄、性别、体重指数及多数基础合并症无显著差异。
- 通过多因素分析比较两组患者特征及围手术期因素以识别ICU死亡危险因素。
- PMX-HP不降低ICU死亡率。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于腹膜炎所致脓毒性休克术后仍需大剂量升压药的患者,作者认为PMX-HP可快速减少术后升压药需求,可能加速休克恢复、减少升压药后遗症并最终改善出院后生活质量;但PMX-HP不降低ICU死亡率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background : This study aimed to evaluate the effect of polymyxin B hemoperfusion (PMX-HP) in patients with peritonitis-induced septic shock who still required high-dose vasopressors after surgical source control. Methods : This retrospective study included adult patients admitted to the surgical intensive care unit (ICU) at Seoul National University Hospital between July 2014 and February 2021 who underwent major abdominal surgery to control the source of sepsis. Patients were divided into two groups based on whether PMX-HP was applied after surgery or not. The primary and secondary endpoints were the vasopressor reduction effect, and in-ICU mortality, respectively. Propensity score matching was performed to compare the vasopressor reduction effect. Results : A total of 338 patients met the inclusion criteria, of which 23 patients underwent PMX-HP postoperatively, whereas 315 patients did not during the study period. Serum norepinephrine concentration decreased over time regardless of whether PMX-HP was applied. However, it decreased more rapidly in the PMX-HP(+) group than in the PMX-HP(-) group. There were no significant differences in demographics including age, sex, body mass index, and most underlying comorbidities between the two groups. Risk factors for in-ICU mortality were identified by comparing patient characteristics and perioperative factors between the two groups using multivariate analysis. Conclusion : For patients with peritonitis-induced septic shock, PMX-HP rapidly reduces the requirement of vasopressors immediately after surgery but does not reduce in-ICU mortality. This effect could potentially accelerate recovery from shock, reduce sequelae from vasopressors, and ultimately improve quality of life after discharge.
参考来源
- Cho A, Oh SY, Lee H, et al. VASOPRESSOR REDUCTION EFFECT OF POLYMYXIN B HEMOPERFUSION IN PATIENTS WITH PERITONITIS-INDUCED SEPTIC SHOCK: A PROPENSITY SCORE-MATCHED ANALYSIS. Shock. 2024. PMID: 38661146. doi:10.1097/SHK.0000000000002375
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。